LATEST NEWS
November 22, 2017 | Company Announcements
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise November 21, 2017 | Company Announcements
Bavarian Nordic Announces Exercise of Clinical Option by the US Government under Contract for Freeze-dried IMVAMUNE Smallpox VaccineNovember 09, 2017 | Company Announcements
Bavarian Nordic Announces Initiation of Phase 2 Booster Study of its Universal RSV Vaccine